Red cell autoantibodies among thalassaemia patients in Hospital Universiti Sains Malaysia.
BACKGROUND
Thalassaemia is one of the major public health problems in Malaysia. Regular monthly blood transfusion remains the main treatment for severe thalassaemia patients. One of the complications of blood transfusion is the formation by the recipients of alloantibodies and autoantibodies against red blood cell (RBC) antigen. The purpose of this study was to determine the prevalence of RBC autoantibodies among multiple-transfused thalassaemic patients in our institution and factors that contribute to its development.


METHODS
A prospective study was conducted in Haematology Laboratory, Hospital Universiti Sains Malaysia between January 2004 and December 2004. A total of 63 thalassaemia patients, who received regular blood transfusion were included in this study. Clinical and serological data were collected and analysed prospectively. Blood samples were subjected to standard blood bank procedures for screening of antibodies and their subsequent identification using reagent of Diamed-ID Gel microtyping system.


RESULTS
There were 49 (77.8 percent) patients with Hb E/beta-thalassaemia, ten (15.9 percent) beta-thalassaemia major, three (4.7 percent) Hb H Constant Spring and one (1.6 percent) Hb H disease. Only one (1.6 percent) patient had autoantibodies. There were no statistical associations found between the formation of autoantibodies with age at the start of transfusion, number of packed cell transfused and splenectomy.


CONCLUSIONS
Our data showed a low autoimmunisation rate in multiple-transfused thalassaemia patients in our hospital.
Noor Haslina
M N
MN
Department of Haematology, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia. drhaslina@kb.usm.my
Ariffin
N
N
Illuni Hayati
I
I
Rosline
H
H
D000293:Adolescent; D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D001789:Blood Group Antigens / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D003298:Coombs Test; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008296:Malaysia; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013789:Thalassemia / Q000097:blood*; D065227:Transfusion Reaction
D001323:Autoantibodies; D001789:Blood Group Antigens